Targeting Mantle Cell Lymphoma With P97 Inhibitors

May 26, 2017
Rekha Rao, PhD

Rekha Rao, PhD, assistant professor, University of Kansas Medical Center, discusses a study of the synergistic activity of p97 inhibitors with histone deacetylase 6 inhibitors in mantle cell lymphoma (MCL).